Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of Myopia Acquisition and Prevention (SMART)
This study is ongoing, but not recruiting participants.
Sponsored by: University Hospital Freiburg
Information provided by: University Hospital Freiburg
ClinicalTrials.gov Identifier: NCT00477620
  Purpose

Purpose To determine whether the use of reading glasses blocks the near work mediated increased incidence of myopia in healthy school children.

Methods SMART enrolled 115 emmetropic children (ages 7-9 years). The children were recruited in the Principality of Liechtenstein. They were randomly assigned to either the control group (n=52) or to receive reading glasses with a lens power of +2.0 dioptres (n=63). The primary outcome measure was progression towards myopia as determined by autorefraction after cycloplegia. The secondary outcome measure was change in biometry measurements of corneal curvature, axial length, anterior chamber depth, crystalline lens thickness, and vitreous chamber depth using partial coherence interferometry.


Condition Intervention
Myopia
Behavioral: Wearing of reading glasses during prolonged near work

MedlinePlus related topics: Eye Wear Methamphetamine
Drug Information available for: Amphetamine Methamphetamine
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Study of Myopia Acquisition and Prevention in a Randomised Trial

Further study details as provided by University Hospital Freiburg:

Study Start Date: April 2004
Estimated Study Completion Date: May 2007
  Eligibility

Ages Eligible for Study:   7 Years to 9 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Emmetropia

Exclusion Criteria:

  • Ametropia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00477620

Sponsors and Collaborators
University Hospital Freiburg
Investigators
Study Chair: Alexaner Reis, PD Dr. med. Augenwerk Liechtenstein
  More Information

Study ID Numbers: FR-2005-01-01
Study First Received: May 23, 2007
Last Updated: May 23, 2007
ClinicalTrials.gov Identifier: NCT00477620  
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital Freiburg:
Myopia
Prevention

Study placed in the following topic categories:
Methamphetamine
Eye Diseases
Amphetamine
Myopia
Refractive Errors

ClinicalTrials.gov processed this record on January 16, 2009